Cargando…

A useful treatment for patients with advanced mixed-type small cell neuroendocrine carcinoma of the prostate: A case report

Treating extended prostatic small cell neuroendocrine carcinoma (PSCNC) is extremely difficult and no standard treatment has yet been established. We experienced a case of advanced mixed-type PSCNC in which the patient achieved long-term survival and local control following combined therapy. Locally...

Descripción completa

Detalles Bibliográficos
Autores principales:	UEMURA, KEI-ICHIRO, NAKAGAWA, GO, CHIKUI, KATSUAKI, MORIYA, FUKUKO, NAKIRI, MAKOTO, HAYASHI, TOKUMASA, SUEKANE, SHIGETAKA, MATSUOKA, KEI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576181/ https://www.ncbi.nlm.nih.gov/pubmed/23426029 http://dx.doi.org/10.3892/ol.2013.1136

Ejemplares similares

Prognostic Value of Absolute Lymphocyte Count in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab plus Ipilimumab
por: Ueda, Kosuke, et al.
Publicado: (2023)

Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report
por: Ueda, Kosuke, et al.
Publicado: (2016)

A Laparoscopic Management Combined with a Flexible Ureteroscope for Ureteral Polyps of More Than 3 cm Length
por: Matsuo, Mitsunori, et al.
Publicado: (2016)

Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide
por: Uemura, Keiichiro, et al.
Publicado: (2011)

Impact of Gleason score of the tumor at the positive surgical margin as a prognostic factor
por: Kurose, Hirofumi, et al.
Publicado: (2022)

Paraganglioma of the urinary bladder: Case report and literature review
por: Kurose, Hirofumi, et al.
Publicado: (2020)

Synchronous primary triple urogenital malignant tumors of kidney, prostate and bladder
por: Kurose, Hirofumi, et al.
Publicado: (2020)

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time
por: Noguchi, Masanori, et al.
Publicado: (2013)

A case of primary mucosa-associated lymphoid tissue lymphoma of the prostate
por: Koga, Noriko, et al.
Publicado: (2009)

Baseline prostate-specific antigen levels following treatment with abiraterone acetate as a prognostic factor in castration-resistant prostate cancer
por: Hiroshige, Tasuku, et al.
Publicado: (2018)

Clinical outcomes of iodine-125 low-dose-rate brachytherapy for localized prostate cancer: a single-institution review in Japan
por: Nakiri, Makoto, et al.
Publicado: (2022)

Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers
por: Noguchi, Masanori, et al.
Publicado: (2018)

Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified median lobe hyperplasia
por: Muraki, Koichiro, et al.
Publicado: (2021)

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial
por: Noguchi, Masanori, et al.
Publicado: (2020)

Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line
por: Ueda, Kosuke, et al.
Publicado: (2013)

Immunological efficacy of herbal medicines in prostate cancer patients treated by personalized peptide vaccine
por: Koga, Noriko, et al.
Publicado: (2017)

Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
por: Nakiri, Makoto, et al.
Publicado: (2022)

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
por: Hingorani, Rittu, et al.
Publicado: (2014)

A Case Report: Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Aggressive Neuroendocrine Component
por: Pham, Quang Duy, et al.
Publicado: (2017)

Bone Marrow Invasion of Small Cell Neuroendocrine Carcinoma of the Endometrium: A Diagnostic Pitfall Mimicking a Haematological Malignancy
por: Kawashima, Ichiro, et al.
Publicado: (2019)

Endoscopic Resection of Ampullary Neuroendocrine Tumor
por: Fukasawa, Hiroyuki, et al.
Publicado: (2017)

Mechanism of Androgen-Independent Stromal Proliferation in Benign Prostatic Hyperplasia
por: Hata, Junya, et al.
Publicado: (2023)

Combined large cell neuroendocrine carcinoma with giant cell carcinoma of the lungs: a case report
por: Hayashi, Satoshi, et al.
Publicado: (2013)

Obesity, Inflammation, and Prostate Cancer
por: Fujita, Kazutoshi, et al.
Publicado: (2019)

Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma
por: Tsai, Harrison K., et al.
Publicado: (2017)

Histocompatibility Leukocyte Antigen‐A2‐restricted and Tumor‐specific Cytotoxic T Lymphocytes from Tumor‐infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
por: Suekane, Shigetaka, et al.
Publicado: (1997)

Immune responses of patients without cancer recurrence after a cancer vaccine over a long term
por: Suekane, Shigetaka, et al.
Publicado: (2022)

Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2013)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer
por: Gonzalez, Paulina, et al.
Publicado: (2023)

The current status of prostate cancer treatment and PSMA theranostics
por: Uemura, Motohide, et al.
Publicado: (2023)

Three-dimensional analysis of interstitial cells in the lamina propria of the murine vas deferens by confocal laser scanning microscopy and FIB/SEM
por: Hiroshige, Tasuku, et al.
Publicado: (2022)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) with pancreatic acinar differentiation: a case report
por: Fujita, Yasuko, et al.
Publicado: (2019)

Pancreatic neuroendocrine tumor with complete replacement of the pancreas by serous cystic neoplasms in a patient with von Hippel-Lindau disease: a case report
por: Maeda, Shimpei, et al.
Publicado: (2017)

Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report
por: Skalický, Adam, et al.
Publicado: (2019)

Mixed neuroendocrine–non‐neuroendocrine neoplasm associated with autoimmune gastritis
por: Mori, Naoko, et al.
Publicado: (2022)

Primary Intracranial Neuroendocrine Tumor of the Skull Base Complicated with Tension Pneumocephalus after Radiotherapy
por: KAMBE, Atsushi, et al.
Publicado: (2021)

PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues
por: Hoshi, Seiji, et al.
Publicado: (2023)

Chemoradiotherapy for Small-Cell Prostate Carcinoma: A Case Report
por: Makita, Kenji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4dpsfnsq7jm1jj0hnp5g61u2sb